AARTI DRUGS
Back to Income Statement
|
AARTI DRUGS Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹2,529 Cr | ₹2,716 Cr | ₹2,489 Cr | ₹2,155 Cr | ₹1,806 Cr |
What is the latest Revenue of AARTI DRUGS ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹2,529 Cr |
| Mar2024 | ₹2,716 Cr |
| Mar2023 | ₹2,489 Cr |
| Mar2022 | ₹2,155 Cr |
| Mar2021 | ₹1,806 Cr |
How is Revenue of AARTI DRUGS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,529 Cr | -6.90 | |
| Mar2024 | ₹2,716 Cr | 9.14 | |
| Mar2023 | ₹2,489 Cr | 15.49 | |
| Mar2022 | ₹2,155 Cr | 19.31 | |
| Mar2021 | ₹1,806 Cr | - | |
Compare Revenue of peers of AARTI DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AARTI DRUGS | ₹3,184.5 Cr | -2.5% | -6.8% | 3.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,704.0 Cr | 3.1% | 6.2% | 13.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,223.0 Cr | -1% | 3.3% | 14.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,928.0 Cr | -0% | 10% | 45.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,368.0 Cr | -0.6% | 3.3% | 16.4% | Stock Analytics | |
| CIPLA | ₹107,043.0 Cr | -2% | -0.6% | -6.1% | Stock Analytics | |
AARTI DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AARTI DRUGS | -2.5% |
-6.8% |
3.5% |
| SENSEX | -4.6% |
-7.5% |
6% |
You may also like the below Video Courses